Assignee
Agomab Therapeutics
BE·2 granted patents·3 pending applications·0 citations·filing 2019–2023
Top patents by PatentIndex Score
5 records- 0173US2024228632A9Anti-met antibodies and uses thereofAgomab Therapeutics·Filed 2023·Application pending·0 cites
- 0265US12084504B2Anti-MET antibodies and uses thereofAgomab Therapeutics·Filed 2021·Granted Sep 10, 2024·0 cites·12 claims
- 0346US11834507B2Anti-MET agonist antibody for use in the treatment of colorectal cancerAgomab Therapeutics·Filed 2019·Granted Dec 5, 2023·0 cites·14 claims
- 0446US2021347901A9Methods for promoting pancreatic islet cell growthAgomab Therapeutics·Filed 2020·Application pending·0 cites
- 0545US2021024639A1Methods for promoting pancreatic islet cell growthAgomab Therapeutics·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Agomab Therapeutics files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →